Ewing tumor fusion proteins block the differentiation of pluripotent marrow stromal cells

Cancer Research

Volumn 63, Issue 13, 2003, Pages 3464-3468

  Torchia, Enrique C ^a   Jaishankar, Sobha ^a,b   Baker, Suzanne J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; ETS GENE; EWING SARCOMA; EWS GENE; FLI 1 GENE; GENE; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STROMA CELL;

ADIPOCYTES; ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA-BINDING PROTEINS; MEDULLOBLASTOMA; MICE; MICE, KNOCKOUT; ONCOGENE PROTEINS; ONCOGENE PROTEINS, FUSION; PLURIPOTENT STEM CELLS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEIN C-FLI-1; PROTO-ONCOGENE PROTEINS; RNA-BINDING PROTEIN EWS; SARCOMA, EWING'S; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0037742405     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature (Lond.), 359: 162-165, 1992.
2. Arvand, A., and Denny, C. T. Biology of EWS/ETS fusions in Ewing's family tumors. Oncogene, 20: 5747-5754, 2001.
3. Sementchenko, V. I., and Watson, D. K. Ets target genes: past, present and future. Oncogene, 19: 6533-6548, 2000.
4. Knoop, L. L., and Baker, S. J. EWS/FLI alters 5′-splice site selection. J. Biol. Chem., 276: 22317-22322, 2001.
5. Cavazzana, A. O., Miser, J. S., Jefferson, J., and Triche, T. J. Experimental evidence for a neural origin of Ewing's sarcoma of bone. Am. J. Pathol., 127: 507-518, 1987.
6. Prockop, D. J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science (Wash. DC), 276: 71-74, 1997.
7. Mezey, E., Chandross, K. J., Harta, G., Maki, R. A., and McKercher, S. R. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science (Wash. DC), 290: 1779-1782, 2000.
8. Brazelton, T. R., Rossi, F. M., Keshet, G. I., and Blau, H. M. From marrow to brain: expression of neuronal phenotypes in adult mice. Science (Wash. DC), 290: 1775-1779, 2000.
9. Ferrari, G., Cusella-De Angelis, G., Coletta, M., Paolucci, E., Stornaiuolo, A., Cossu, G., and Mavilio, F. Muscle regeneration by bone marrow-derived myogenic progenitors. Science (Wash. DC), 279: 1528-1530, 1998.
10. Phinney, D. G., Kopen, G., Isaacson, R. L., and Prockop, D. J. Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation. J. Cell. Biochem., 72: 570-585, 1999.
11. May, W. A., Lessnick, S. L., Braun, B. S., Klemsz, M., Lewis, B. C., Lunsford, L. B., Hromas, R., and Denny, C. T. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol. Cell. Biol., 13: 7393-7398, 1993.
12. Persons, D. A., Allay, J. A., Allay, E. R., Ashmun, R. A., Orlic, D., Jane, S. M., Cunningham, J. M., and Nienhuis, A. W. Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis. Blood, 93: 488-499, 1999.
13. Groth, A., Weber, J. D., Willumsen, B. M., Sherr, C. J., and Roussel, M. F. Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases. J. Biol. Chem., 275: 27473-27480, 2000.
14. Jaishankar, S., Zhang, J., Roussel, M. F., and Baker, S. J. Transforming activity of EWS/FLI is not strictly dependent upon DNA-binding activity. Oncogene, 18: 5592-5597, 1999.
15. Zhu, X., Kwon, C. H., Schlosshauer, P. W., Ellenson, L. H., and Baker, S. J. PTEN induces G(1) cell cycle arrest and decreases cyclin D3 levels in endometrial carcinoma cells. Cancer Res., 61: 4569-4575, 2001.
16. Palmero, I., and Serrano, M. Induction of senescence by oncogenic Ras. Methods Enzymol., 333: 247-256, 2001.
17. Kovar, H., Jug, G., Aryee, D. N., Zoubek, A., Ambros, P., Gruber, B., Windhager, R., and Gadner, H. Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors. Oncogene, 15: 2225-2232, 1997.
18. Wei, G., Antonescu, C. R., de Alava, E., Leung, D., Huvos, A. G., Meyers, P. A., Healey, J. H., and Ladanyi, M. Prognostic impact of 1NK4A deletion in Ewing sarcoma. Cancer (Phila.), 89: 793-799, 2000.
19. Tsuchiya, T., Sekine, K., Hinohara, S., Namiki, T., Nobori, T., and Kaneko, Y. Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma. Cancer Genet. Cytogenet., 120: 91-98, 2000.
20. Lopez-Guerrero, J. A., Pellin, A., Noguera, R., Carda, C., and Llombart-Bosch, A. Molecular analysis of the 9p21 locus and p53 genes in Ewing family tumors. Lab. Investig., 81: 803-814, 2001.
21. Deneen, B., and Denny, C. T. Loss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation. Oncogene, 20: 6731-6741, 2001.
22. Woodbury, D., Schwarz, E. J., Prockop, D. J., and Black, I. B. Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res., 61: 364-370, 2000.
23. Kopen, G. C., Prockop, D. J., and Phinney, D. G. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc. Natl. Acad. Sci. USA, 96: 10711-10716, 1999.
24. Eliazer, S., Spencer, J., Ye, D., Olson, E., and Ilaria, R. L., Jr. Alteration of mesodermal cell differentiation by EWS/FLI-1, the oncogene implicated in Ewing's sarcoma. Mol. Cell. Biol., 23: 482-492, 2003.
25. Olson, E. N., Spizz, G., and Tainsky, M. A. The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation. Mol. Cell. Biol., 7: 2104-2111, 1987.
26. Lassar, A. B., Thayer, M. J., Overell, R. W., and Weintraub, H. Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1. Cell, 58: 659-667, 1989.
27. Look, A. T. Oncogenic transcription factors in the human acute leukemias. Science (Wash. DC), 278: 1059-1064, 1997.
28. Tenen, D. G. Disruption of differentiation in human cancer: AML shows the way. Nat. Rev. Cancer, 3: 89-101, 2003.
29. Truong, A. H., and Ben-David, Y. The role of Fli-1 in normal cell function and malignant transformation. Oncogene, 19: 6482-6489, 2000.
30. Welford, S. M., Hebert, S. P., Deneen, B., Arvand, A., and Denny, C. T. DNA binding domain-independent pathways are involved in EWS/FLI1-mediated oncogenesis. J. Biol. Chem., 276: 41977-41984, 2001.
31. Arvand, A., Welford, S. M., Teitell, M. A., and Denny, C. T. The COOH-terminal domain of FLI-1 is necessary for full tumorigenesis and transcriptional modulation by EWS/FLI-1. Cancer Res., 61: 5311-5317, 2001.